Searched for
PERFUSE THERAPEUTICS
Bayer to buy Perfuse Therapeutics in up to $2.45 billion dealBayer is set to acquire Perfuse Therapeutics in a deal valued up to $2.45 billion. This strategic move aims to enhance Bayer's eye care tre...- For those with a 3- to 5-year investing perspective: 5 small-caps, 3 with an upside potential of up to 63%There are some sectors where the opportunity is so large that there is a high probability that even a small-cap company can grow in size. J...
- Briota wins ZS PRIZE healthcare innovation award; startups Ayati Devices and UrvogelBio are runners upZS Associates, a worldwide management consulting and technology organisation, launched the ZS PRIZE healthcare innovation award to identify...
- Dr Reddy's Laboratories launches Regadenoson injection in US marketThe injection is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate ex...
- Jubilant Life signs deals for diagnostic product supplyJubilant DraxImage Montreal Canada has signed long-term contracts with distribution networks in the US for supply of products used for diag...
- Jubilant Life arm gets Australia TGA nod for lung scan drugJubilant Pharma, through one of its units JDI, has received approval from TGA, Australia, for Lyophilized kit for preparation of Technetium...
Load More